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Background: Case reports and case series studies suggest a positive association between intussusception and
celiac disease (CD).
Methods: We contacted Sweden’s 28 pathology departments and obtained data on 29,096 patients with
biopsy-verified CD (equal to Marsh stage 3) through biopsy reports. Patients with CD were matched for age, sex,
calendar period and county of residence with up to five reference individuals from the general population
(n = 144,522). Cases of intussusception were identified from nationwide inpatient, hospital-based outpatient and
day-surgery data from the Swedish Patient Register.
Odds ratios (ORs) for future CD in patients with intussusception were estimated using conditional logistic
regression.
Results: 34 (0.12%) individuals with CD had a diagnosis of intussusception vs. 143 (0.10%) reference individuals,
suggesting that intussusception was not a risk factor for later CD (OR = 1.17; 95% confidence interval (CI) = 0.82–
1.67). The OR for CD in patients with at least two records of intussusception was 0.40 (95% CI = 0.06–2.99).
In contrast, a post-hoc analysis showed that CD was associated with a statistically significantly increased risk of
intussusception after CD diagnosis (hazard ratio = 1.95; 95% CI = 1.01–3.77); however, this analysis was based on
only 12 cases with both CD and intussusception.
Conclusion: We found no association between intussusception and future CD; and a mostly modest increased risk
of intussusception after a diagnosis of CD.
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Intussusception is a condition in which a segment of in-
testine invaginates into another section of intestine.
Signs and symptoms of intussusception include acute
pain, nausea, lethargy, vomiting and sometimes bleeding
from the rectum (“red currant jelly”) [1]. Although intus-
susception generally remits spontaneously, in a number
of cases either contrast enema or surgery is needed to
treat the disorder [2]. The causes of intussusception in-
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distribution, and reproduction in any mediumbut organic disorders such as malignancy tend to pre-
dominate in adults.
Celiac disease (CD) is a chronic inflammatory small
intestinal disorder that occurs in about 1–2% of the gen-
eral population [3,4]. Undiagnosed CD is characterized
by small bowel inflammation [5] and will sometimes
cause small bowel wall edema [6], intestinal lymph node
swelling [7] and dysmotility [7] but also ulcers and stric-
tures [8]. It has therefore been suggested that untreated
CD may be linked to intussusception; a number of case-
reports and case series substantiate this hypothesishesis
[9-14]. In a recent paper from a tertiary institution in
the US [14], 3/252 (1.2%) of children with newly diag-
nosed CD had a history of intussusception compared
with 0.07% of the child population attending this center.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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CD, however, due to small numbers or lack of controls,
none of these studies have estimated relative risks or
odds ratios (ORs) [9-14].
The main objective of this study was therefore to
examine the association between intussusception and
later biopsy-verified CD in a large nationwide population-
based case–control study. In a post-hoc analysis we exam-
ined the risk of intussusception in patients who already
had a diagnosis of CD.
Methods
We identified patients with intussusception through the
Swedish Patient Register [15] (data on inpatient care,
hospital-based outpatient care and day-care surgery). In-
tussusception data were linked to data on CD obtained
from biopsy reports at Sweden’s 28 pathology registers
[16]. Linkages were performed using the Swedish per-
sonal identity number (PIN) [17].
Intussusception
Cases with intussusception were identified from the
Swedish Patient Register [15] by reference to relevant
International Classification of Disease (ICD) codes ICD-
7: 570.0; ICD-8: 560.0; ICD-9: 560A; and ICD-10: K56.1.
In subanalyses we restricted intussusception to cases
with surgery or to those who had radiological interven-
tion (code TJG30 or 4780) for intussusception. In a sep-
arate analysis we examined the risk of CD in patients
with at least two recorded health care contacts that were
due to intussusception.
The Swedish Patient Register started in 1964 and since
1987 the register has nationwide coverage. Day-surgery
data were added from 1997 and hospital-based out-
patient data since 2001 [15].
Celiac disease
In 2006–2008 we collected small intestinal biopsy report
data from all pathology departments (n = 28) in Sweden.
The biopsies were performed between 1969 and 2008. IT
personnel carried out computerized searches for arrival
date of biopsies, PIN [17], morphology and topography
(duodenum and jejunum). CD was defined as having a bi-
opsy with villous atrophy (VA, equals Marsh stage 3) [18]
according to the Swedish SnoMed classification. We did
not require patients to have a positive antibodies against
tissue transglutaminase (TTG), endomysium (EMA), or
gliadin for a CD diagnosis, but in a random subset of pa-
tients with VA and available data on CD serology about
88% were positive for either of these antibodies at the time
of biopsy [16]. An earlier validation of 114 patients with
VA found that 108 (95%) had CD [16]. Approximately
79% of individuals with CD had gastrointestinal symptoms
before biopsy and 35% had anemia.Controls
Each individual undergoing biopsy was matched with up
to five controls for age, sex, calendar period and county
of residence. Controls were identified from the Total
Population Register by the Swedish government agency,
Statistics Sweden and had no previous duodenal/jejunal
biopsy.
We then excluded individuals whose biopsy may have
originated from the ileum, CD individuals lacking a ser-
ial number from Statistics Sweden or having no matched
controls since all analyses were carried out per stratum.
The remaining individuals were identical to those in our
study on mortality in CD [19]. Thus, the final sample on
which this study is based was 29,096 individuals with
CD and 144,522 matched controls.
Statistics
We used conditional logistic regression to estimate ORs
for CD and earlier intussusception. The conditional ap-
proach entails that each individual with CD is only com-
pared with his or her controls within the same stratum.
We also present percentages of CD patients and controls
with a previous diagnosis of intussusception.
In pre-defined subanalyses we examined intussuscep-
tion and CD in relation to sex, age (0–19, 20–39, 40–59
and ≥60 years at age of diagnosis) and calendar period
(1989, 1990–1999 and 2000-) at CD diagnosis.
In another pre-defined subanalysis we examined the
association between intussusception and CD in children
aged <2 years (CD: n = 4,589). We did so for two rea-
sons. First, in Sweden, CD is often diagnosed in this age
group [20], and second, as opposed to adults in which
intussusception may be caused by cancers [11], under-
lying cancers are unusual in childhood when most intus-
susception is idiopathic. We therefore hypothesized that
the association with CD would be strongest with idio-
pathic intussusception in infancy and childhood. For
consistency, we also examined the risk of intussuscep-
tion in individuals diagnosed with CD ≥2 years of age
(CD: n = 24,507). In a post-hoc analysis we excluded all
intussusception occurring before the age of 2 years (not
equal to the previous analysis in which we examined risk
of CD after the age of 2 years but included intussuscep-
tions occurring before age 2) and calculated OR for
future CD.
We also examined the risk of future CD in patients
with at least 2 health care contacts for intussusception
(repeated intussusceptions) of which at least one intus-
susception had to occur before CD diagnosis. Having at
least 2 records of intussusception will increase the likeli-
hood that the patient really had intussusception.
Cancer is sometimes the underlying cause of intussus-
ception [11] and CD has been linked to both lym-
phoproliferative [21] and gastrointestinal cancer [22] (at





Total, n 144,522 29,096
Age at celiac diagnosis, years
(median, range)
* 30; 0–95
Age 0–19, n (%) 58,852 (40.7) 11,802 (40.6)
Age 20–39, n (%) 26,385 (18.3) 5,312 (18.3)
Age 40–59, n (%) 32,254 (22.3) 6,477 (22.3)
Age ≥60, n (%) 27,031 (18.7) 5,505 (18.9)
Entry year (median, range) 1998, 1969–2008 1998, 1969–2008
Females, n (%) 89,544 (62.0) 18,005 (61.9)
Males, n (%) 54,978 (38.0) 11,091 (38.1)
Calendar year
−1989, n (%) 20,378 (14.1) 4,105 (14.1)
1990–99, n (%) 59,874 (41.4) 12,059 (41.4)
2000, n (%) 64,270 (44.5) 12,932 (44.4)
Country of birth
Nordic# 136,279 (94.3) 28,139 (96.7)
Data on intussusception
Intussusception n (%) 143 (0.10) 34 (0.12)
Age at first intussusception,
years (median, range)
1 (0–60) 3 (0–68)
Intussusception with
surgery/radiology, n (%)
31 (0.02) 8 (0.03)
* Reference individuals were matched for age. The median age at matching
was 30 years (range 0–95 years).
# Sweden, Denmark, Finland, Norway and Iceland.
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that a positive association between CD and intussuscep-
tion would be due to cancer we performed a separate
analysis in which we excluded all individuals (CD pa-
tients and controls) who ever had a diagnosis of cancer
according to the Swedish Cancer Registry (CD: n =
25,869). The Swedish Cancer Registry began in 1958.
About 99% of all cancers are morphologically verified
[24] and almost 100% of all cancers are reported to this
register each year [24].
Post-hoc analysis: CD and risk of future intussusception
In a post-hoc analysis we examined the risk of future in-
tussusception in patients with CD. This analysis was
done to explore whether the null relationship that we
found between intussusception and later CD was inde-
pendent of temporal sequence. In the prospective ana-
lysis we used a cohort study design. Individuals with CD
were compared with matched reference individuals and
followed from biopsy (or matching date) until first event
of intussusception, emigration, death or end of follow-
up (Dec 31, 2009), whichever occurred first. We used
Cox regression models to calculate hazard ratios (HRs)
for the risk of future intussusception in CD. All analyses
were internally stratified, i.e. one individual with CD was
only compared with his or her matched reference indi-
viduals (within a stratum) before a summary estimate
for the whole CD population was calculated. This ap-
proach eliminates the influence of matching variables,
such as sex, age, county of residence and calendar year
at CD diagnosis. The prospective cohort analysis was
based on 29,060 individuals with no earlier record of in-
tussusception and 144,304 matched reference individuals.
SPSS version 20.0 (SPSS Inc, Chicago, IL, USA) was
used for all analyses. Statistical significance was defined
as 95% confidence intervals (CIs) for risk estimates (ORs
and HRs) not including 1.0.
Ethics
The study was approved by the regional ethical review
board in Stockholm, Sweden. Since none of the partici-
pants was contacted and individual information was
“anonymized” before the analyses, informed consent was
not required by the board.
Results
The median age at CD diagnosis was 30 years (range 0–
95) (Table 1). Most patients with CD were diagnosed
after 1990 since this study was based on computerized
biopsy reports and computerized registers were usually
introduced in this decade. Data on the sub-cohort of
children diagnosed with CD <2 years of age are
presented in Additional file 1. Slightly more than 6 of 10
study participants (all ages) were women.Intussusception and risk of CD
Of 29,096 individuals with CD, 34 (0.12%) had a
diagnosis of intussusception vs. 143/144,522 of the
controls (0.10%). Hence, we found no association be-
tween intussusception and later CD (OR = 1.17; 95%
CI = 0.82–1.67). The OR for having a diagnosis of CD
was 1.31 (95% CI = 0.64–2.68) within 1 year after intus-
susception, 0.56 (95% CI = 0.17–1.78) 1–< 5 years after
intussusception and 1.31 (95% CI = 0.84–2.05) ≥5 years
after intussusception.
The risk of future CD was similar in females
(OR = 0.97; 95% CI = 0.57–1.66) and males (OR = 1.40;
95% CI = 0.86–2.28) (Table 2), and there were no signifi-
cant differences in ORs according to age at CD diagno-
sis or calendar year (Table 2). Adjustment for education
and country of birth (Nordic vs. Non-Nordic) did not
affect our ORs (data not shown).
Subanalyses
When we restricted our dataset to children <2 years of
age (at diagnosis of CD or at date of matching), 6 indi-
viduals with CD had a previous intussusception vs. 32
controls. Intussusception was no risk factor for CD in
Table 2 Intussusception and risk of later celiac disease
Subgroup Intussusceptions,
N








Males 19 66 1.40; 0.86–2.28 0.176 0.323
Females 15 77 0.97; 0.57–1.66 0.922
Age*
<20 yrs 20 103 0.97; 0.61–1.54 0.902 0.256
20–39 yrs 8 23 1.67; 0.78–3.66 0.186
40–59 yrs 3 6 2.34; 0.64–8.62 0.201
60+ yrs 3 11 1.34; 0.39–4.66 0.645
Calendar
period*
−1989 7 21 1.59; 0.71–3.56 0.258 0.292
1990–1999 14 54 1.27; 0.72–2.22 0.407
2000–2008 13 68 0.96; 0.54–1.70 0.881
*At time of celiac disease diagnosis.
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2.14) (Table 3). Table 3 shows additional data.
Similarly, intussusception was no risk factor for having
a diagnosis of CD after 2 years of age (OR = 1.24; 95%
CI = 0.83–1.86). However, we did find a statistically sig-
nificant association (OR = 2.11; 95% CI = 1.26–3.53) in a
post-hoc analysis that only examined intussusceptions






OR; 95% CI OR; 95% CI
Overall 0.94; 0.42–2.14 1.27; 0.60–2.69
Sex
Males 1.55; 0.56–4.31 1.07; 0.31–3.63
Females 0.53; 0.13–2.16 1.42; 0.55–3.67
Age*
<20 yrs Not estimated 0.80; 0.24–2.62
20–39 yrs Not estimated 2.88; 0.93–8.91
40–59 yrs Not estimated 2.50; 0.23–27.57
≥60 yrs Not estimated Not estimated§
Calendar period*
−1989 1.41; 0.44–4.54 2.31; 0.48–11.30
1990–1999 0.59; 0.14–2.39 0.94; 0.28–3.14
2000–2008 1.23; 0.15–9.82 1.33; 0.39–4.52
*At time of celiac disease diagnosis. #Radiological intervention
for intussusception.
§ No cases of previous intussusception in the CD group vs. four cases in the
control group.Restricting our exposure to intussusception with either
radiological intervention or surgery, the OR for future
CD was 1.27 (95% CI = 0.60–2.69).
One patient with CD vs. 13 controls had ≥2 records of
intussusception (out of which at least one intussuscep-
tion occurred before CD diagnosis and study entry). This
outcome corresponded to a non-significant OR of 0.40
for future CD (95% CI = 0.06–2.99). In eleven of the
fourteen (1 + 13) patients with ≥2 records of intussus-
ception, did the two records correspond to the same in-
tussusception (e.g. follow-up visit shortly after first
diagnosis). All three patients with ≥30 days between the
two intussusceptions (our definition of different epi-
sodes), were controls.
Excluding study participants who had a diagnosis of
cancer at some stage in life, the OR for future CD in pa-
tients with intussusception was 1.10 (95% CI = 0.76–
1.59) (31/25,869 CD patients vs. 140/130,041 controls
had an earlier diagnosis of intussusception).
Celiac disease and risk of future intussusception
Using a prospective cohort approach, a post-hoc analysis
found that 12 of 29,060 individuals with CD had a diag-
nosis of intussusception after CD onset (expected n = 6),
corresponding to a hazard ratio and relative risk of 1.95
(95% CI = 1.01–3.77, p = 0.046).
Discussion
To our knowledge this is the first case–control study
examining intussusception and risk of future CD. It
found no association between intussusception and CD
(overall OR = 1.17). In a post-hoc analysis intended to
confirm the null relationship between prior intussuscep-
tion and CD before diagnosis we instead found that pa-
tients with diagnosed CD were at an almost twofold
increased risk of later intussusception.
Most literature on CD and intussusception has been
limited to case reports or case series [9-13,25]. Germann
et al. suggest that intussusception in CD has a mild clin-
ical course [25]. Intussusception may take place in the
duodenum or jejunum but may occur in other parts of
the intestine. In our study we were unable to differenti-
ate between intussusceptions in the small intestine and
the colon. If intussusception is associated with CD, it is
most likely associated with small intestinal intussuscep-
tion and thus the inclusion of colonic intussusception
may have diluted a positive relationship. Still, the overall
OR for future CD was very close to 1.0, and if there had
been a significant association between previous intussus-
ception and CD, this would have appeared in our data.
Reilly et al. reported that 1.2% of their celiac children
had experienced a known intussusception [14] but since
the authors do not present any statistical comparison
with the general population this may or may not
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Reilly et al. [14] by different source populations (nation-
wide approach vs. tertiary institution), and larger num-
ber of celiac patients (29,096 vs. 254).
In a recent paper we studied the role of surgery in
adult intussusception [11]. In that case series 8/196 (4%)
patients with intussusception had CD [11]. In a paper
looking at the risk of intussusception in patients with a
diagnosis of CD 14/880 (1.6%) developed intussuscep-
tion during follow-up [13]. In both these series, with
strong associations between CD and intussusception,
participants were recruited from single tertiary centers,
making it is possible that this procedure selected cases
with more severe CD and intussusception [11,13], or
that these patients were at higher risk of undergoing in-
vestigation or contacting health care for a number of
disorders. We have previously shown that the relative
risk of another disorder in CD (tuberculosis) is twice as
high in CD patients identified through hospital records
[26] as in patients identified through biopsy reports [27].
Further, the risk of mortality in CD seems higher in pa-
tients with a hospital record of CD [28] than in patients
diagnosed through biopsy reports [19]. More than 96%
of pediatricians and gastroenterologists in Sweden per-
form a biopsy in at least 90% of patients with suspected
CD before diagnosis [29]. Other strengths of our paper
include the high specificity of VA for CD. When two
independent reviewers manually scrutinized more than
1500 biopsy reports, very few individuals had other
comorbidities than CD (0.3% of patients with VA had in-
flammatory bowel disease and 0.2% had Helicobacter
pylori). The nationwide ascertainment of CD yielded a
large number of CD cases, which contributed to high
statistical power. We were therefore able to stratify for
age, sex and calendar period at CD diagnosis.
Restricting our analyses to intussusception with radio-
logical intervention and surgery did not affect the OR
(1.27). Only after we restricted our analyses to individ-
uals with intussusception after the age of 2 years, did we
find a positive association between intussusception and
future CD. We urge caution when interpreting these
data since they made up a post-hoc finding and could be
due to chance. Still, these data may reflect a true associ-
ation between inflammation from undiagnosed CD in
older children and adults and secondary intussusception.
This study has some limitations. We used a case–con-
trol design to examine the association between previous
intussusception and future CD. This design means that
we did not screen individuals with intussusception for
serological markers. Still, if any, patients with intussus-
ception would have been more likely to undergo investi-
gation for CD and this would have driven up the OR for
CD. The lack of serological data can therefore not ex-
plain our null findings for later CD risk.We did not have access to radiological data such as
computed tomography and thus could not confirm the
intussusception diagnosis. However, in several analyses
we increased the specificity of intussusception through
various restrictions of the dataset and this had only mar-
ginal effects on the ORs. Nor did we screen CD patients
for intussusception with MRI, CT or ultrasound [7]. Thus,
we have no information on the association between CD
and intussusception that did not require health care.
We know of no earlier incidence study of intussuscep-
tion in Sweden but a study from nearby Germany found
an incidence of 60/100,000 person-years in children <1
year of age [30]. When we examined control children
who were born in 1987 or later (when the Swedish Pa-
tient Registry was complete) in our dataset, there were
37 intussusceptions in the first year of life corresponding
to an incidence of 83/100,000 (37/44,759 person-years).
This incidence suggests that the low OR of our study is
unlikely to be due to underreporting of intussusceptions.
Finally, despite the large number of patients, we can-
not rule out a weak association between intussusception
and later CD since the upper 95% CI reached 1.67.
Early versions of Rotavirus immunizations have been
linked to intussusception [31], and we lacked immu-
nization data. However a recent study from Sweden [32]
found no association between childhood immunizations
and CD, and rotavirus immunizations have not yet been
included in the general childhood immunization pro-
gram in Sweden. Hence, biased immunization coverage
in CD children is unlikely to explain our results.
Conclusion
In conclusion, this study found no association between
intussusception and CD before CD diagnosis (undiag-
nosed CD), but did find a twofold increased risk of in-
tussusception after CD diagnosis. However, because only
12/29,060 (0.04%) individuals with CD developed intus-
susception during follow-up, intussusception is probably
a rare complication in CD. This study does not support
CD screening in patients with intussusception.
Additional file
Additional file 1: Characteristics of study participants with
diagnosis of CD <2 years of age.
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